Mark Stielow
About Mark Stielow
Mark Stielow serves as the Vice President of US Manufacturing & Technical Operations at Adaptimmune, where he leverages his extensive experience in autologous T-cell manufacturing and compliance practices in drug development. He has held various leadership roles in prominent companies, including Johnson & Johnson and Abbott Laboratories, and possesses a strong educational background in Chemical Engineering and an MBA.
Current Role at Adaptimmune
Mark Stielow serves as the Vice President of US Manufacturing & Technical Operations at Adaptimmune, a position he has held since 2021. In this role, he is responsible for overseeing manufacturing operations and technical processes within the United States. His leadership is instrumental in preparing the company for its first Biologics License Application (BLA) and the commercial launch of TCR therapy. Stielow's extensive experience in the field enables him to effectively manage complex manufacturing challenges and drive operational excellence.
Previous Experience at Johnson & Johnson
Mark Stielow held multiple positions at Johnson & Johnson from 2011 to 2018. He served as Senior Director of Operations Readiness for Convergent Products and later as Sr. Director/Group Lead for Operations Readiness from 2013 to 2016. His responsibilities included ensuring operational readiness and compliance in the development of medical products. Stielow also worked as Director of Product Management & Lifecycle R&D during his tenure, focusing on product strategy and lifecycle management.
Background in Manufacturing and Technical Operations
Stielow has a strong background in manufacturing and technical operations, particularly in the pharmaceutical and medical device industries. He worked at Adaptimmune as Senior Director of Manufacturing & Technical Operations and Director of Manufacturing Science & Technology, where he gained expertise in autologous T-cell manufacturing. His previous roles at Centocor Biologics and Abbott Laboratories further solidified his operational and engineering skills, particularly in drug/device combination products.
Education and Expertise
Mark Stielow earned his MBA in Finance & Strategy from Northwestern University's Kellogg School of Management, completing his studies from 1993 to 1997. He also holds a Bachelor of Science degree in Chemical Engineering from the University of Wisconsin-Madison, obtained from 1983 to 1988. His educational background complements his extensive expertise in compliance practices related to drug and device development, ensuring adherence to regulatory standards.
Consulting and Early Career Experience
Before his roles in manufacturing and operations, Mark Stielow worked as a Consultant and Consulting Manager at Pittiglio Rabin Todd & McGrath from 1998 to 2002. His early career included various engineering and operations roles at Abbott Laboratories from 1989 to 1998 and positions at Centocor in business management and global planning. This diverse experience has contributed to his comprehensive understanding of the industry.